2022

Call for Action: High Time to Prioritise Health in the EU Artificial Intelligence Act

Introducing the TRIPS Flexibilities Navigator

Artificial Intelligence Act – A long awaited report surfaces

HAI Statement on Tentative Agreement on TRIPS and COVID-19

2021

Transparency: Bringing the Issue to Life

Working with the European Parliament

TRIPS Waiver: The Push Continues

Talking Medicine Pricing

Clinical Trial Data and the Risk of Bias

Getting Hack to Reality

C-TAP has not (yet) lived up to high expectations

A Pandemic Response Lacking Moral Leadership

Annual Report 2020 – A Year Like No Other

Challenging the IP Protection Framework

Health Action International at 40 – A Word from Executive Director, Tim Reed

2020

There is no UHC without Universal Medicines Coverage

Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic

What do the next five years have in store for the European Medicines Agency?

Dutch institutions failing to register results of clinical trials

COVID-19 risks turning back the clock on years of essential development work

Barriers and facilitators of access to Internationally Controlled Essential Medicines in Kenya

Reflections on the World Health Assembly

COVID-19 And Its Far-Reaching Health Impacts in Sub-Saharan Africa

EU Must Not Miss its Chance on WHO Technology Pool

TRIPS-flexibilities in Health Crises and Beyond

Reversed gains in the advancement of SRHR in Kenya; effects of COVID-19

COVID-19, social determinants and frontline workers

Health Action International Working from Home

HAI Follows Dutch Government Advice in Response to COVID-19

2019

Halving snakebite deaths and disabilities by 2030 – How can we reach WHO’s goal?